Physician

Ana Maria Van Der Wall, MD

According to 2025 Medicare claims, Ana Wall, MD (NPI: 1265672018) practices medical oncology in the North Port-Bradenton-Sarasota, FL market, with the plurality of this provider's patient population coming from Manatee, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 34205-2557.

Wall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 908 traditional Medicare patients, billed 301,380 HCPCS/CPT codes, and received $4,935,154 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 813 prescription claims across 199 beneficiaries totaling $3,147,483 in drug costs, led by Revlimid (Lenalidomide). 2019 DME data shows 49 claims. Open Payments data shows 60 records totaling $1,308. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,373,156 to $4,935,154. Similarly, Part D prescription costs have risen steadily, from $1,257,116 to $3,147,483. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.5M$4.9M2015 Medicare payment: $1,373,156 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,968,633 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,086,404 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,921,455 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,307,601 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,491,999 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,633,618 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,792,725 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,661,772 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,935,154 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201571797,447$1,373,156
2016701278,864$1,968,633
2017682208,610$2,086,404
2018797270,853$2,921,455
2019743240,634$3,307,601
2020848276,729$4,491,999
2021813310,497$4,633,618
2022859352,051$4,792,725
2023923384,950$4,661,772
2024908301,380$4,935,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.1M2015 Drug cost: $1,257,116 (USD; Tot_Drug_Cst)2016 Drug cost: $1,251,082 (USD; Tot_Drug_Cst)2017 Drug cost: $1,602,540 (USD; Tot_Drug_Cst)2018 Drug cost: $1,164,346 (USD; Tot_Drug_Cst)2019 Drug cost: $1,379,719 (USD; Tot_Drug_Cst)2020 Drug cost: $1,239,510 (USD; Tot_Drug_Cst)2021 Drug cost: $1,631,235 (USD; Tot_Drug_Cst)2022 Drug cost: $1,950,648 (USD; Tot_Drug_Cst)2023 Drug cost: $2,295,354 (USD; Tot_Drug_Cst)2024 Drug cost: $3,147,483 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015133576$1,257,116
2016134721$1,251,082
2017157856$1,602,540
2018163730$1,164,346
2019153670$1,379,719
2020189736$1,239,510
2021195779$1,631,235
2022187639$1,950,648
2023183760$2,295,354
2024199813$3,147,483

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.9K$5.7K2015 Medicare payment: $628 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $3,174 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $5,734 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,919 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R24$628
2016N/R62$3,174
2017N/RN/RN/R
2018N/R52$5,734
2019N/R49$3,919
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3501,019$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more239303$64
96372Injection of drug or substance under skin or into muscle269883$10
36415Insertion of needle into vein for collection of blood sample7412,604$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6302,526$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide752,058$1,271,089
IbrancePalbociclib421,098$494,153
VenclextaVenetoclax19568$291,063
NubeqaDarolutamide19570$269,620
BrukinsaZanubrutinib32960$217,983

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.60$1,308Merck Sharp & Dohme LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ana Maria Van Der Wall, MD?

Tedicare shows public-source Medicare data for Ana Maria Van Der Wall, MD (NPI 1265672018), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ana Maria Van Der Wall, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ana Maria Van Der Wall, MD?

Ana Maria Van Der Wall, MD is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Ana Maria Van Der Wall, MD have Open Payments data?

Ana Maria Van Der Wall, MD has 60 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.